A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: Ixabepilone (Ixempra)|DRUG: Paclitaxel (Taxol)
Sponsor: SCRI Development Innovations, LLC
Collaborators: Bristol-Myers Squibb